TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive In Brief: CDP Services Wins ASC Planning Contract; Jury Finds Sarin Guilty of Embezzlement July 17, 1992
TCL Archive In Brief: Owens Gives Up Hopkins Hospital Presidency, Resume Full Time Role As Center Director July 15, 1988
TCL Archive Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers April 25, 1980
